| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 29 | 1 | 2005 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.905 | 21 | 0 | 2003 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2003 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.100 | None | 0.889 | 17 | 0 | 1998 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2012 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2012 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2004 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2012 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2017 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2012 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.100 | None | 1.000 | 15 | 3 | 2004 | 2020 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2017 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2013 | 2019 | ||||||||
|
tetraspanin 33 | 0.606 | 0.731 | 7.0E-05 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2009 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1997 | 2019 | ||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2003 | 2019 | |||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 2003 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2003 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.390 | None | 1.000 | 9 | 0 | 1991 | 2019 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 2008 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2009 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.070 | None | 0.857 | 7 | 2 | 1998 | 2017 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2020 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1997 | 2018 |